News

Vitiligo, a skin disorder characterized by depigmentation, remains one of the most prevalent causes of skin color loss globally. While...

The growing prevalence of urticaria, commonly known as hives, is spurring significant advancements in treatment development. Increased allergic responses and...

Shingles, a painful condition caused by the same virus responsible for chickenpox, continues to challenge medical professionals, but new research...

A recent clinical trial has underscored the potential of combining the Janus kinase (JAK) inhibitor baricitinib with narrow-band ultraviolet B...

The global hidradenitis suppurativa (HS) market is on track for substantial growth in the coming years, according to a new...

A new study has revealed that patients with advanced-stage cancer who are treated with immune checkpoint inhibitors (ICIs) face a...

The U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) date for Dermavant’s tapinarof...

Hidradenitis suppurativa (HS), a chronic and debilitating autoinflammatory skin condition, remains a significant challenge for both patients and healthcare providers....

Hidradenitis suppurativa (HS), a chronic and often painful skin condition, can cause significant physical and emotional distress if not addressed...

Hidradenitis suppurativa (HS), a chronic inflammatory skin condition, presents significant diagnostic challenges. Imaging modalities such as high-frequency ultrasound (US) and...